Background: Unique amongst brain stimulation tools, transcranial direct current stimulation (tDCS) currently lacks an easy method for individualizing dosage.
Introduction
Transcranial direct current stimulation (tDCS) is an appealing brain stimulation method 2 due to its efficacy in treating multiple neurological and psychiatric conditions (1) (2) (3) (4) , relatively 3 cheap cost (5, 6) , excellent safety profile (7) , and ease of use that could lead to self-4 administration(7-9). However, tDCS currently does not have a method or biomarker to confirm In Visit 2, each participant underwent a structural magnetic resonance imaging (MRI) 6 8 scan. A vitamin E capsule was used as a fiducial to mark each participant's previously 6 9 determined scalp target for the TMS/TES MT. This allowed the motor hotspot location to later be 7 0 visualized in MRICro. 7 1 Preparing MRI Scans for E-Field Modeling 7 2 We used the MRICro program to visualize the fiducial marking the left hemispheric motor 7 3 hotspot location and noted the X, Y, and Z coordinates for the fiducial location (See Figure 2) . 7 4 In addition, we approximated the cathodal electrode location over the left deltoid by finding the 7 5 lowest location on the left shoulder visible on the MRI scan (See Figure 1) . For our E-field 7 6 modeling, we used "Realistic vOlumetric-Approach to Simulate Transcranial Electric 7 7 Stimulation" (ROAST)" software (27) , which allowed us to use the individualized electrode 7 8 placements, sizes, and orientations used to determine TES MT. 7 9 Prospective ROAST E-Field Modeling 8 0
Most tDCS E-field modeling studies use modeling to determine the E-field produced by a 8 1 uniform tDCS current placed on the scalp (e.g. What is the E-field produced by 2mA of 8 2 stimulation?). In this study, we had the opposite question: To produce an E-field of a 1.00V/m at 8 3 a certain spot in the cortex, what would be the individualized, reverse-calculated tDCS dose for 8 4 the electrode on the scalp? 8 5 We used ROAST V2.7 for our tDCS E-field modeling as it allowed us to customize the 8 6 electrode sizes and locations for each participant based on their structural MRI scans (27) . We 8 7 customized the TES pad electrode sizes (Anode: 35mm x 20mm x 3mm; Cathode: 55mm x 8 8 42mm x 3mm), locations (left motor hotspot, left deltoid), and orientations (anterior-to-posterior) 8 9 to reproduce the TES montage in the ROAST code using MATLAB R2015a. ROAST E-Field Modeling Methodology-Within Individual Analysis 9 1 We sought to determine the reverse-calculated tDCS dose that would be necessary to 9 2 cause a 1.00V/m E-field at the cortex in each individual by reverse-calculating the ROAST model by computing four E-field models per participant. Using the exact electrode locations 9 4 used to acquire TES MT, we modeled the E-fields produced from tDCS currents of: 1mA, 3mA, 9 5 5mA, and 7mA. We plotted these E-field estimates (in V/m) along the X-axis against the tDCS 9 6 current input on the Y-axis. We also included the point of 0mA input producing a 0V/m E-field for 9 7 a total of 5 points in the linear regression. 9 8 To determine the E-field produced in each model, we measured the E-field at the voxel 9 9 directly underneath the center of the anodal electrode that was placed over the left motor for that subject at that location. We then computed a fifth ROAST model at this reverse- Our reverse computation may seem overly elaborate, as theoretically, the electric field is current to produce any desired electric field. This 'shortcut' may prove true for future work, and 1 1 0 general values. However, the reverse-calculated dose that emerges from the individualized 1 1 1 linear model by putting in different current amplitudes is not exactly linear, and we sought in this paper to rigorously test for these assumptions. In the future researchers and clinicians might be Following E-field modeling, we plotted each individual's reverse-calculated tDCS dose relationship between TMS MT and reverse-calculated tDCS dose (Figure 3 ). We used this 1 1 8 same method to then assess the relationship between TES MT and the reverse-calculated The mean TMS MT was 40.19% of machine output (SD = 12.7%, range = 20-67.3%). The mean TES MT was 61.35mA (SD = 14.91mA, range = 37.1-82.35mA). Reverse-calculated tDCS Dose: Actual Electrode Placement and Sizes The mean reverse-calculated tDCS dose to produce a 1.00V/m E-field in the motor cortex using actual electrode placements was 6.38mA (SD = 1.34mA, range = 3.86 to TMS MT x Reverse-calculated tDCS Dose Linear Regression acquiring the TES MT (mean reverse-calculated tDCS dose = 6.38mA, SD = 1.34mA, range = This regression model used the same electrode placement and sizes used to determine 1 3 8 the TES MT that were previously used in the TMS MT regression in Figure 3 (mean reverse- calculated tDCS dose = 6.38mA, SD = 1.34mA, range = 3.86 to 10.21mA). In this regression, The equation for the linear regression is: Reverse-calculated tDCS Dose = 0.0643 * For example, if an individual had a TES MT of 60mA, the reverse-calculated tDCS dose to 1 4 6 produce a 1.00V/m E-field at their motor cortex would be 6.29mA. Notably, this reverse- We examined the relationship between TMS MT and TES MT by comparing the We conducted a study in 29 healthy individuals in which we used both TMS and TES 1 5 6 motor thresholds (MT), combined with anatomical neuroimaging and E-field modelling to 1 5 7 determine an individualized dosing paradigm for tDCS. This E-field modeling paradigm, was 1 5 8 used to determine an individual's reverse-calculated tDCS dose to produce an E-field of 1.00V/m. We found that an individual's transcranial electrical stimulation (TES) MT predicted predicted 50.9% of the reverse-calculated tDCS dose variance across our sample. In contrast, a person's transcranial magnetic stimulation (TMS) MT did not correlate 1 6 4 with the reverse-calculated tDCS dose to produce a 1.00V/m E-field at the cortex. It is unclear 1 6 5 why TES MT but not TMS MT correlates with the modelled tDCS dose, but it is likely that the tDCS modeling better captures electrical energy current than that produced by TMS due to 1 6 7 differing mechanisms. Our finding that TMS MT did not correlate with TES MT corroborates the 1 6 8 idea that TMS MT may not predict reverse-calculated tDCS dose due to a different mechanism 1 6 9 (electromagnetic rather than electrical stimulation). This study suggests several points. First, it is possible to significantly predict acquired and analyzed structural MRI scans for each participant in this study, in the future this 1 7 4 regression approach could potentially allow TES MT acquisition alone to determine an individual's reverse-calculated tDCS dose. However, before this regression comparing TES MT and reverse-calculated tDCS dose can be used widely, our results need to be tested for 1 7 7 replication and then shown to be valid in some form of a tDCS study measuring behavioral Second, the reverse-calculated tDCS dose to cause an E-field at a particular threshold 1 8 0 at the cortex varies widely between individuals (3.86 to 10.21mA to produce a 1.00V/m E-field at 1 8 1 the cortex). This variability in reverse-calculated tDCS dose is substantial. To illustrate the range actual electrode position and size model would need a reverse-calculated tDCS dose that is 1 8 4 265% higher than the individual who needed the lowest reverse-calculated tDCS dose 1 8 5 (3.86mA). In addition, the inter-individual variance exists regardless of the intended threshold in 1 8 6 any region of the brain. For example, in order to produce a 1.00V/m induced electrical field at 1 8 7 the motor cortex, the range of tDCS dose needed was from 3.86 to 10.21 mA (average 6.38 mA 1 8 8 tDCS dose at scalp). If we moved the entire scale average to instead average 2.0mA at the tDCS study), it would underdose any individual needing above 2.0mA, particularly the person tDCS dose is needed for consistent dosing across individuals and studies. Third, and perhaps controversially, if a 1.00V/m E-field threshold is necessary to cause a 1 9 5 spike in neuronal firing, the results from this study support the idea that a uniform 1-2mA tDCS 1 9 6 dose is likely insufficient to reach the cortex with a large effect in many participants. While 1 9 7 acknowledging that there may actually be some increases in neuronal resting membrane 1 9 8 potential at lower than 1.00V/m, our models using this threshold showed that no participant's 1 9 9 reverse-calculated tDCS dose was below 3.86mA and the average reverse-calculated tDCS 2 0 0 dose was 6.38mA. tDCS likely has effects at intensities below the 1.00V/m assumption we used, but depending on the reverse-calculated threshold, these results suggest that some, if not There were several limitations of this study. Using E-field modeling, even when it has minimally necessary E-field magnitude needed to excite cortical tissue, and then scaling our 2 2 9 findings up or down to fit calculate the true reverse-calculated tDCS dosage for each person. field modeling or stand alone, can be used to determine a theoretical reverse-calculated tDCS MT to reverse-calculated tDCS dose can be used to individually dose tDCS, predicting 2 3 5 approximately 50% of the dose variance in tDCS studies. Moreover, these regressions reveal the wide range (i.e. 3.86 to 10.21mA) between participants, underscoring the need to further 2 3 7 develop and evaluate the utility of TES MT combined with E-field modeling for dosing tDCS. 
ROAST E-Field Modeling x TMS MT and TES MT Methodology-Group Level Analyses
1 3 0
This linear regression evaluated the relationship between TMS MT and reverse-

TES MT x Reverse-calculated tDCS Dose Linear Regression
Conflict of Interest Statement:
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